Breaking News

Endo Appoints Corporate Development VP

April 29, 2014

Valeant veteran brings specialty pharma experience

Hemanth J. Varghese, Ph.D., CFA, has been appointed executive vice president of corporate development and strategy at Endo International. Dr. Robert Cobuzzi, who previously served in this role will now serve as senior vice president, U.S. branded pharmaceuticals R&D strategy and operations. Dr. Varghese will report to Rajiv De Silva, Endo's president and chief executive officer.
 
Dr. Varghese brings corporate development and general management experience in specialty pharmaceuticals, most recently serving as senior vice president and general manager vision care for Bausch & Lomb, a division of Valeant Pharmaceuticals. Dr. Varghese also held senior leadership roles at Valeant, including senior vice president of corporate development and general manager of Valeant's Neurology & Other business unit.
 
"We are excited to announce the addition of Hemanth to the Endo executive team. His accomplishments and experience in corporate development and integrations will allow us to accelerate the execution of our strategy as we continue to expand our business through value creating acquisitions and partnerships," said Mr. De Silva. "Hemanth's track record of success will play a significant role as we execute against our strategy to become a leading specialty healthcare company."
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks